Yes, by preventing HBV infection, the hepatitis B vaccine significantly reduces the risk of developing liver cancer. Studies have shown that widespread vaccination can lead to a dramatic decrease in the incidence of hepatocellular carcinoma, particularly in areas with high rates of HBV infection. This makes the hepatitis B vaccine a powerful tool in cancer prevention.
